<H1>Chapter DOI: 10.1208/aapsj070242<br/>Cited-By Count: 26</H1><table border="1" width="30%"><tr><td>Total References</td><td>89</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>84</td></tr><tr><td>BibStructured Count</td><td width="10%">88</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>66</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>4</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>5</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>5</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>4</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.<Emphasis Type="Italic">Pharmacopsychiatry</Emphasis>. 1996;29:2&#8211;11.</td><td><a href=http://dx.doi.org/10.1055/s-2007-979535>10.1055/s-2007-979535</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, JournalTitle, FirstPage, ArticleTitle, VolumeID, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Nutt DJ. The neuropharmacology of serotonin and noradrenaline in depression.<Emphasis Type="Italic">Int Clin Psychopharmacol</Emphasis>. 2002;17:S1-S12.</td><td><a href=http://dx.doi.org/10.1097/00004850-200201000-00001>10.1097/00004850-200201000-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibChapter</td><td>Rush A, Ryan N. Current and emerging therapeutics for depression. In: Davis K, Charney D, Coyle J, Nemeroff C. eds.<Emphasis Type="Italic">Neuropsychopharmacology: The Fifth Generation of Progress</Emphasis>. New York: Raven Press; 2002:1081&#8211;1095.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1176/appi.ajp.159.7.1251-a>10.1176/appi.ajp.159.7.1251-a</a></td><td><b>CrossRef-Web</b></td>
<td>Year</td><td>CrossRef</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1997;283:1305&#8211;1322.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Ban TA. Pharmacotherapy of depression: a historical analysis.<Emphasis Type="Italic">J Neural Transm</Emphasis>. 2001;108: 707&#8211;716.</td><td><a href=http://dx.doi.org/10.1007/s007020170047>10.1007/s007020170047</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Richelson E. The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors.<Emphasis Type="Italic">Psychopharmacol Bull</Emphasis>. 2002;36:133&#8211;150.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.<Emphasis Type="Italic">Depress Anxiety</Emphasis>. 1997;6:10&#8211;18.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1520-6394(1997)6:1&lt;10::AID-DA2&gt;3.0.CO;2-9>10.1002/(SICI)1520-6394(1997)6:1&lt;10::AID-DA2&gt;3.0.CO;2-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.<Emphasis Type="Italic">BMJ</Emphasis>. 1993;306:683&#8211;687.</td><td><a href=http://dx.doi.org/10.1136/bmj.306.6879.683>10.1136/bmj.306.6879.683</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Fava M. New approaches to the treatment of refractory depression.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2000;61:26&#8211;32.</td><td><a href=http://dx.doi.org/10.4088/JCP.v61n0107>10.4088/JCP.v61n0107</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine a 2003 update.<Emphasis Type="Italic">Clin Ther.</Emphasis>, 2003;25:2138&#8211;2154.</td><td><a href=http://dx.doi.org/10.1016/S0149-2918(03)80210-2>10.1016/S0149-2918(03)80210-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2003;64:13&#8211;17.</td><td><a href=http://dx.doi.org/10.4088/JCP.v64n0104>10.4088/JCP.v64n0104</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Shelton RC. The dual-action hypothesis: does pharmacology matter?.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2004;65:5&#8211;10.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Barker EL, Perlman MA, Adkins EM, et al. High affinity recognition of serotonin transporter antagonists defined, by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates, species-selective recognition of citalopram and mazindol.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1998;273:19459&#8211;19468.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.31.19459>10.1074/jbc.273.31.19459</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Ravna AW, Sylte I, Dahl SG. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;307:34&#8211;41.</td><td><a href=http://dx.doi.org/10.1124/jpet.103.054593>10.1124/jpet.103.054593</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:7782&#8211;7785.</td><td><a href=http://dx.doi.org/10.1073/pnas.89.16.7782>10.1073/pnas.89.16.7782</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Barker EL, Moore KR, Rakhshan F, Blakely RD. Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1999;19:4705&#8211;4717.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Paczkowski FA, Bryan-Lluka LJ. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.<Emphasis Type="Italic">Brain Res Mol Brain Res</Emphasis>. 2001;97:32&#8211;42.</td><td><a href=http://dx.doi.org/10.1016/S0169-328X(01)00295-9>10.1016/S0169-328X(01)00295-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Roubert C, Cox PJ, Bruss M, Hamon M, Bonisch H, Giros B. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2001;276:8254&#8211;8260.</td><td><a href=http://dx.doi.org/10.1074/jbc.M009798200>10.1074/jbc.M009798200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Paczkowski FA, Bonisch H, Bryan-Lluka LJ. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.<Emphasis Type="Italic">Pharmacogenetics</Emphasis>. 2002;12:165&#8211;173.</td><td><a href=http://dx.doi.org/10.1097/00008571-200203000-00010>10.1097/00008571-200203000-00010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Roman DL, Walline CC, Rodriguez GJ, Barker EL. Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2003; 479:53&#8211;63.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2003.08.056>10.1016/j.ejphar.2003.08.056</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Barker EL, Blakely RD. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1996;50:957&#8211;965.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Schloss P, Williams DC. The serotonin transporter: a primary target for antidepressant drugs.<Emphasis Type="Italic">J Psychopharmacol</Emphasis>. 1998;12:115&#8211;121.</td><td><a href=http://dx.doi.org/10.1177/026988119801200201>10.1177/026988119801200201</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Vetulani J, Nalepa I. Antidepressants: past, present and future.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2000;405:351&#8211;363.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(00)00565-3>10.1016/S0014-2999(00)00565-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD: Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1997;17:45&#8211;57.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters.<Emphasis Type="Italic">J. Biol Chem</Emphasis>. 1998;273:2458&#8211;2466.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.4.2458>10.1074/jbc.273.4.2458</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.<Emphasis Type="Italic">Science</Emphasis>. 1999;285:763&#8211;766.</td><td><a href=http://dx.doi.org/10.1126/science.285.5428.763>10.1126/science.285.5428.763</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Donati RJ, Rasenick MM. G protein signaling and the molecular basis of antidepressant action.<Emphasis Type="Italic">Life Sci</Emphasis>. 2003;73:1&#8211;17.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(03)00249-2>10.1016/S0024-3205(03)00249-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Ramamoorthy S, Cool DR, Mahesh VB, et al. Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1993;268:21626&#8211;21631.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2004;65:1462&#8211;1474.</td><td><a href=http://dx.doi.org/10.1124/mol.65.6.1462>10.1124/mol.65.6.1462</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Miller KJ, Hoffman BJ. Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1994;269:27351&#8211;27356.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2005;25:29&#8211;41.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.3754-04.2005>10.1523/JNEUROSCI.3754-04.2005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins.<Emphasis Type="Italic">Biochem Soc Trans</Emphasis>. 2001;29:722&#8211;728.</td><td><a href=http://dx.doi.org/10.1042/BST0290722>10.1042/BST0290722</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Quick MW. Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons.<Emphasis Type="Italic">Int J Dev Neurosci</Emphasis>. 2002;20:219&#8211;224.</td><td><a href=http://dx.doi.org/10.1016/S0736-5748(02)00021-7>10.1016/S0736-5748(02)00021-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Quick MW. Regulating the conducting states of a mammalian serotonin transporter.<Emphasis Type="Italic">Neuron</Emphasis>. 2003;40:537&#8211;549.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(03)00605-6>10.1016/S0896-6273(03)00605-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2000;20:7571&#8211;7578.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Rausch JL, Gillespie CF, Fei Y. Antidepressant effects on kinase gene expression patterns in rat brain.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 2002;334:91&#8211;94.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(02)01106-0>10.1016/S0304-3940(02)01106-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Gelenberg AJ, Chesen CL. How fast are antidepressants?.<Emphasis Type="Italic">J Clin Psychiatry</Emphasis>. 2000;61:712&#8211;721.</td><td><a href=http://dx.doi.org/10.4088/JCP.v61n1002>10.4088/JCP.v61n1002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibChapter</td><td>Potter WZ, Hollister LE. Antidepressant agents. In: Katzung BG, ed.<Emphasis Type="Italic">Basic &amp; Clinical Pharmacology</Emphasis>. New York: Lange Medical Books/McGraw-Hill; 2004:482&#8211;496.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Horschitz S, Hummerich R, Schloss P. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.<Emphasis Type="Italic">Neuroreport</Emphasis>. 2001;12: 2181&#8211;2184.</td><td><a href=http://dx.doi.org/10.1097/00001756-200107200-00027>10.1097/00001756-200107200-00027</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Benmansour S, Cecchi M, Morilak DA. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1999;19:10494&#8211;10501.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:6766&#8211;6772.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Gould GG, Pardon MC, Morilak DA, Frazer A. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2003;28:1633&#8211;1641.</td><td><a href=http://dx.doi.org/10.1038/sj.npp.1300236>10.1038/sj.npp.1300236</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Kugaya A, Seneca NM, Snyder PJ, et al. Changes in human<Emphasis Type="Italic">in vivo</Emphasis> serotonin and dopamine transporter availabilities during chronic antidepressant administration.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2003;28:413&#8211;420.</td><td><a href=http://dx.doi.org/10.1038/sj.npp.1300036>10.1038/sj.npp.1300036</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness.<Emphasis Type="Italic">Hum Psychopharmacol</Emphasis>. 2001;16:229&#8211;236.</td><td><a href=http://dx.doi.org/10.1002/hup.251>10.1002/hup.251</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Alvarez JC, Gluck N, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1999;66:617&#8211;624.</td><td><a href=http://dx.doi.org/10.1053/cp.1999.v66.103402001>10.1053/cp.1999.v66.103402001</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, FirstPage, ArticleTitle, VolumeID, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR46</td><td>BibArticle</td><td>H&#233;bert C, Habimana A, &#201;lie R, Reader TA. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.<Emphasis Type="Italic">Neurochem Int.</Emphasis> 2001;38:63&#8211;74.</td><td><a href=http://dx.doi.org/10.1016/S0197-0186(00)00043-7>10.1016/S0197-0186(00)00043-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Yau JL, Kelly PA, Olsson T, Noble J, Seckl JR. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1999;261:183&#8211;185.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(98)00997-5>10.1016/S0304-3940(98)00997-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Lima L, Urbina M. Serotonin transporter modulation in blood lymphocytes from patients with major depression.<Emphasis Type="Italic">Cell Mol Neurobiol</Emphasis>. 2002;22:797&#8211;804.</td><td><a href=http://dx.doi.org/10.1023/A:1021869310702>10.1023/A:1021869310702</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Schloss P, Henn FA. New insights into the mechanisms of antidepressant therapy.<Emphasis Type="Italic">Pharmacol Ther</Emphasis>. 2004;102:47&#8211;60.</td><td><a href=http://dx.doi.org/10.1016/j.pharmthera.2004.02.001>10.1016/j.pharmthera.2004.02.001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Pi&#241;eyro G, Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action.<Emphasis Type="Italic">Pharmacol Rev</Emphasis>. 1999;51:533&#8211;591.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.<Emphasis Type="Italic">J Psychiatry Neurosci</Emphasis>. 2004;29:252&#8211;265.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Hensler JG. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2002;26:565&#8211;573.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(01)00395-5>10.1016/S0893-133X(01)00395-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Ase AR, Reader TA, Hen R, Riad M, Descarries L Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2001;78:619&#8211;630.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2001.00437.x>10.1046/j.1471-4159.2001.00437.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Daws LC, Gerhardt GA, Frazer A. 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus.<Emphasis Type="Italic">Neurosci Lett</Emphasis>. 1999;266:165&#8211;168.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(99)00277-3>10.1016/S0304-3940(99)00277-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Daws LC, Gould GG, Teicher SD, Gerhardt GA, Frazer A. 5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo.<Emphasis Type="Italic">J Neurochem</Emphasis>. 2000;75:2113&#8211;2122.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2000.0752113.x>10.1046/j.1471-4159.2000.0752113.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Malagi&#233; I, David DJ, Jolliet P, Hen R, Bourin M, Gardier AM. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2002;443:99&#8211;104.</td><td><a href=http://dx.doi.org/10.1016/S0014-2999(02)01604-7>10.1016/S0014-2999(02)01604-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Neumaier JF, Root DC, Hamblin MW. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 1996;15:515&#8211;522.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(96)00095-4>10.1016/S0893-133X(96)00095-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis>. 1994;51:248&#8211;251.</td><td><a href=http://dx.doi.org/10.1001/archpsyc.1994.03950030084009>10.1001/archpsyc.1994.03950030084009</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, ArticleTitle, Author_FamilyName_1, JournalTitle, Year</td><td>CrossRef</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Shalom G, Gur, E, Van de Kar LD, Newman ME. Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex.<Emphasis Type="Italic">Naunyn Schmiedebergs Arch Pharmacol</Emphasis>. 2004;370:84&#8211;90.</td><td><a href=http://dx.doi.org/10.1007/s00210-004-0958-x>10.1007/s00210-004-0958-x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Ansah TA, Ramamoorthy S, Montanez S, Daws LC, Blakely RD. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;305:956&#8211;965.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.047134>10.1124/jpet.102.047134</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1993;90:2542&#8211;2546.</td><td><a href=http://dx.doi.org/10.1073/pnas.90.6.2542>10.1073/pnas.90.6.2542</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression.<Emphasis Type="Italic">J Neurochem</Emphasis>. 1996;66:2621&#8211;2624.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.1996.66062621.x>10.1046/j.1471-4159.1996.66062621.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.<Emphasis Type="Italic">Science</Emphasis>. 1996;274:1527&#8211;1531.</td><td><a href=http://dx.doi.org/10.1126/science.274.5292.1527>10.1126/science.274.5292.1527</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Rausch JL, Johnson ME, Fei YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2002;51:723&#8211;732.</td><td><a href=http://dx.doi.org/10.1016/S0006-3223(01)01283-5>10.1016/S0006-3223(01)01283-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2002;7:1115&#8211;1119.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4001141>10.1038/sj.mp.4001141</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2000;23:587&#8211;590.</td><td><a href=http://dx.doi.org/10.1016/S0893-133X(00)00132-9>10.1016/S0893-133X(00)00132-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2004;174:525&#8211;529.</td><td><a href=http://dx.doi.org/10.1007/s00213-003-1562-3>10.1007/s00213-003-1562-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Ozaki N, Goldman D, Kaye WH, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2003;8:933&#8211;936.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4001365>10.1038/sj.mp.4001365</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;64:440&#8211;446.</td><td><a href=http://dx.doi.org/10.1124/mol.64.2.440>10.1124/mol.64.2.440</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Smith RS. The macrophage theory of depression.<Emphasis Type="Italic">Med Hypotheses</Emphasis>. 1991;35:298&#8211;306.</td><td><a href=http://dx.doi.org/10.1016/0306-9877(91)90272-Z>10.1016/0306-9877(91)90272-Z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Connor TJ, Leonard BE. Depression stress and immunological activation: the role of cytokines in depressive disorders.<Emphasis Type="Italic">Life Sci</Emphasis>. 1998;62:583&#8211;606.</td><td><a href=http://dx.doi.org/10.1016/S0024-3205(97)00990-9>10.1016/S0024-3205(97)00990-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Pfennig A, Kunzel HE, Kern N, et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2005;57:336&#8211;342.</td><td><a href=http://dx.doi.org/10.1016/j.biopsych.2004.11.017>10.1016/j.biopsych.2004.11.017</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.<Emphasis Type="Italic">Mol Psychiatry</Emphasis>. 2002;7:468&#8211;473.</td><td><a href=http://dx.doi.org/10.1038/sj.mp.4000995>10.1038/sj.mp.4000995</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Capuron L, Neurauter G, Musselman DL, et al. Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2003;54:906&#8211;914.</td><td><a href=http://dx.doi.org/10.1016/S0006-3223(03)00173-2>10.1016/S0006-3223(03)00173-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression.<Emphasis Type="Italic">Prog Neuropsychopharmacol Biol Psychiatry</Emphasis>. 2005;29:201&#8211;217.</td><td><a href=http://dx.doi.org/10.1016/j.pnpbp.2004.11.003>10.1016/j.pnpbp.2004.11.003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Bschor T, Baethge C, Adli M, Lewitzka U, Eichmann U, Bauer M. Hypothalamic-pituitary-thyroid system activity during lithium augm entation therapy in patients with unipolar major depression.<Emphasis Type="Italic">J Psychiatry Neurosci</Emphasis>. 2003;28:210&#8211;216.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR77</td><td>BibArticle</td><td>Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachatre G. Relationship between psychotropic drugs and thyroid function: a review.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 1998;149:127&#8211;135.</td><td><a href=http://dx.doi.org/10.1006/taap.1998.8367>10.1006/taap.1998.8367</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR78</td><td>BibArticle</td><td>Shelton RC, Winn S, Ekhatore N, Loosen PT. The effects of antidepressants on the thyroid axis in depression.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 1993;33:120&#8211;126.</td><td><a href=http://dx.doi.org/10.1016/0006-3223(93)90311-Z>10.1016/0006-3223(93)90311-Z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR79</td><td>BibArticle</td><td>Duval F, Mokrani MC, Crocq MA, et al. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode.<Emphasis Type="Italic">Arch Gen Psychiatry</Emphasis>. 1996;53:833&#8211;840.</td><td><a href=http://dx.doi.org/10.1001/archpsyc.1996.01830090081012>10.1001/archpsyc.1996.01830090081012</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, FirstPage, ArticleTitle, Year, JournalTitle, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR80</td><td>BibArticle</td><td>Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.<Emphasis Type="Italic">J Neurosci</Emphasis>. 1996;16:2365&#8211;2372.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR81</td><td>BibArticle</td><td>Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2004;56:151&#8211;160.</td><td><a href=http://dx.doi.org/10.1016/j.biopsych.2004.04.010>10.1016/j.biopsych.2004.04.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR82</td><td>BibArticle</td><td>Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.<Emphasis Type="Italic">Biol Psychiatry</Emphasis>. 2003;54:70&#8211;75.</td><td><a href=http://dx.doi.org/10.1016/S0006-3223(03)00181-1>10.1016/S0006-3223(03)00181-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR83</td><td>BibArticle</td><td>Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders.<Emphasis Type="Italic">Neuromolecular Med</Emphasis>. 2004;5:11&#8211;25.</td><td><a href=http://dx.doi.org/10.1385/NMM:5:1:011>10.1385/NMM:5:1:011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR84</td><td>BibArticle</td><td>Coppell AL, Pei Q, Zetterstrom TS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment.<Emphasis Type="Italic">Neuropharmacology</Emphasis>. 2003;44:903&#8211;910.</td><td><a href=http://dx.doi.org/10.1016/S0028-3908(03)00077-7>10.1016/S0028-3908(03)00077-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR85</td><td>BibArticle</td><td>Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.<Emphasis Type="Italic">J Neurosci</Emphasis>. 2002;22:3262&#8211;3268.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR86</td><td>BibArticle</td><td>Pullar IA, Boot JR, Broadmore RJ. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2004;493:85&#8211;93.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2004.04.029>10.1016/j.ejphar.2004.04.029</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR87</td><td>BibArticle</td><td>Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Nicol Ferrier I. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.<Emphasis Type="Italic">Neuropsychopharmacology</Emphasis>. 2004;29:1538&#8211;1545.</td><td><a href=http://dx.doi.org/10.1038/sj.npp.1300471>10.1038/sj.npp.1300471</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR88</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Bao</span> <span style='background:#DDDDDD'>AM</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Hestiantoro</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#FFFF80'>Van</span> <span style='background:#BCBCBC'>Someren</span> <span style='background:#DDDDDD'>EJ</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Swaab</span> <span style='background:#DDDDDD'>DF</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Zhou</span> <span style='background:#DDDDDD'>JN</span></span></aug>. <span style='background:#CCCCFF'>Colocalization of corticotropin-releasing hormone and oestrogen receptor-{alpha} in the paraventricular nucleus of the hypothalamus in mood disorders</span>. <span style='background:#CCFF99'><i>Brain</i></span>. <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR89</td><td>BibArticle</td><td>Dableh LJ, Yashpal K, Rochford J, Henry JL. Antidepressant-like effects of neurokin receptor antagonists in the forced swim test in the rat.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2005;507:99&#8211;105.</td><td><a href=http://dx.doi.org/10.1016/j.ejphar.2004.11.024>10.1016/j.ejphar.2004.11.024</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>